Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Research Technician



+44 (0)20 7594 7897p.fenwick




Technician Room 229BGuy Scadding BuildingRoyal Brompton Campus





Peter Fenwick

Peter Fenwick is a Senior Research Technician at the National Heart and Lung Institute, Imperial College London.

He studied Biology at Sussex University followed by an MSc in Environmental Science at Lancaster University. He firstly worked as an endocrinologist at Bourn Hall Clinic,then subsequently as a Research Scientist at Addenbrookes Hospital, Cambridge, then as a Herbal Medicine Technician for the degree course in Herbal Medicine at Middlesex University. He first came to work at Imperial College London as a Research Technician in the Department of Infectious Diseases at Hammersmith Hospital in 1999.

Since 2001 he has worked as a Research Technician in Airways Disease at the National Heart and Lung Institute, during which time he has contributed to the publication of papers, and has presented his research at international conferences including the American Thoracic Society (ATS) and the European Respiratory Society Annual meetings.  In 2005, he was awarded a British Lung Foundation Travel award to attend the ATS. His current research involves understanding the underling signal transduction pathways leading to the aberrant  macrophage and epthelial cell response that contribute to the pathophysiology of chronic obstructive pulmonary disease.  



Ombredane HCJ, Fenwick PS, Barnes PJ, et al., 2023, Temporal Release of IL-1 Family Members from Virally Infected Airway Epithelial Cells Suggests IL-36γ Is the Early Responder, American Journal of Respiratory Cell and Molecular Biology, Vol:68, ISSN:1044-1549, Pages:339-341

Baker JR, Fenwick PS, Koss CK, et al., 2022, Imbalance between IL-36 receptor agonist and antagonist drives neutrophilic inflammation in COPD, Jci Insight, Vol:7, ISSN:2379-3708

Singh R, Belchamber K, Fenwick P, et al., 2021, Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD, Respiratory Research, Vol:22, ISSN:1465-9921, Pages:1-11

Finney L, Glanville N, Farne H, et al., 2021, Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon, Journal of Allergy and Clinical Immunology, Vol:147, ISSN:0091-6749, Pages:510-519.e5


Baker JR, Fenwick PS, Owles HB, et al., 2021, IL-36? - a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease, European-Respiratory-Society (ERS) International Congress, EUROPEAN RESPIRATORY SOC JOURNALS LTD, ISSN:0903-1936

More Publications